OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of new 2-oxoquinoxalinyl-1,2,4-triazoles as antitumor VEGFR-2 inhibitors
Merve Zengin, Oya Ünsal Tan, Reem K. Arafa, et al.
Bioorganic Chemistry (2022) Vol. 121, pp. 105696-105696
Closed Access | Times Cited: 23

Showing 23 citing articles:

QSAR analysis of VEGFR-2 inhibitors based on machine learning, Topomer CoMFA and molecule docking
Hao Ding, Fei Xing, Lin Zou, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 10

Rationale design, synthesis, cytotoxicity evaluation, andin silicomechanistic studies of novel 1,2,3-triazoles with potential anticancer activity
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 25, pp. 12206-12216
Closed Access | Times Cited: 30

Visible‐Light‐Driven Multicomponent Radical Cascade Versatile Alkylation of Quinoxalinones Enabled by Electron Donor Acceptor Complex in Water
Bin Sun, Xiaoli Tang, Xiaohui Zhuang, et al.
Advanced Synthesis & Catalysis (2023) Vol. 365, Iss. 7, pp. 1020-1026
Closed Access | Times Cited: 17

Design, Synthesis, and Antitumor Evaluation of Sophoridine Derivatives as Topoisomerase I Inhibitors Based on the Topomer CoMFA Model
Yakun Zhang, Jianbo Tong, Hongyan Zhang, et al.
Journal of Molecular Structure (2025) Vol. 1335, pp. 142005-142005
Closed Access

1,2,4-Triazole-Tethered Indolinones as New Cancer-Fighting Small Molecules Targeting VEGFR-2: Synthesis, Biological Evaluations and Molecular Docking
Ahmed E. Elsawi, Mai I. Shahin, Hager A. Elbendary, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 81-81
Open Access | Times Cited: 4

Design and Synthesis of Quinoxaline Hybrids as Modulators of HIF-1a, VEGF, and p21 for Halting Colorectal Cancer
Mohammed Salah Ayoup, Ahmed R. Rabee, Hamida Abdel‐Hamid, et al.
ACS Omega (2024) Vol. 9, Iss. 23, pp. 24643-24653
Open Access | Times Cited: 3

Mimicry of sorafenib: novel diarylureas as VEGFR2 inhibitors and apoptosis inducers in breast cancer
Magda M. F. Ismail, Ebtehal M. Husseiny, Mona H. Ibrahim
New Journal of Chemistry (2023) Vol. 47, Iss. 24, pp. 11565-11576
Closed Access | Times Cited: 6

Visible‐Light‐Driven Three‐Component Reaction of Unactivated Alkenes Enables Access to Monofluoro γ‐Amino Acids
Guodong Ju, Zhibin Huang, Jian Liu, et al.
European Journal of Organic Chemistry (2023) Vol. 26, Iss. 36
Open Access | Times Cited: 4

In silico ’ repurposing new inhibitors of EGFR and VEGFR-2 kinases via biophysical mechanisms
Mona H. Ibraheim, Ibrahim Maher, Ibrahim Khater
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 18, pp. 9571-9586
Closed Access | Times Cited: 4

Design, synthesis, and ex vivo anti-drug resistant cervical cancer activity of novel molecularly targeted chalcone derivatives
Zheng Yang, Yu Wang, Mourboul Ablise, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107498-107498
Closed Access | Times Cited: 1

Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers
Reda G. Yousef, Ibrahim H. Eissa, Hazem Elkady, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 24, pp. 2583-2598
Open Access | Times Cited: 1

Synthesis, structure elucidation and cytotoxic activities of 2,5-disubstituted-1,3,4-thiadiazole and l,2,4-triazole-3-thione derivatives
Levent KANDEMİR, Sevgi Karakuş, Suna Özbaş, et al.
Journal of Research in Pharmacy (2022) Vol. 26(4), Iss. 26(4), pp. 941-953
Open Access | Times Cited: 6

Integration of Hybridization Strategies in Pyridine–Urea Scaffolds for Novel Anticancer Agents: Design, Synthesis, and Mechanistic Insights
Sreenivasulu Godesi, Hossam Nada, Joohan Lee, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 4952-4952
Open Access | Times Cited: 3

Synthesis and evaluation of antiproliferative and mPGES-1 inhibitory activities of novel carvacrol-triazole conjugates
İlkay Küçükgüzel, İlker Demirbolat, Necla Kulabaş, et al.
Organic Communications (2022), Iss. 4, pp. 356-377
Open Access | Times Cited: 5

Synthesis of Imidazole‐2,3‐dihydrothiazole Compounds as VEGFR‐2 Inhibitors and Their Support with in Silico Studies
Derya Osmani̇ye, Nurnehir BALTACİ, Berkant Kurban, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 9
Closed Access | Times Cited: 2

Targeting EGFR and VEGFR-2 Kinases With Nanoparticles: A Computational Approach for Cancer Therapy Advancement
Ibrahim Khater, Aaya Nassar
Cancer Investigation (2024) Vol. 42, Iss. 2, pp. 176-185
Closed Access

Computational quest, synthesis and anticancer profiling of 3-methyl quinoxaline-2-one-based active hits against the tyrosine kinase
Priyadarsini Raj, A. Samuel, Anitha Kothandapani
Future Journal of Pharmaceutical Sciences (2024) Vol. 10, Iss. 1
Open Access

A comprehensive review on triazoles as anticancer agents
Lala Ahmadova, Merve Camci Eren, Özlen Güzel Akdemir
Journal of Research in Pharmacy (2024) Vol. 29, Iss. 2, pp. 639-666
Open Access

ELECTRON WITHDRAWING GROUP EFFECT ON BIOLOGICAL ACTIVITIES OF PYRIMIDINE HYBRIDS AS POTENTIAL ANTI-MATRIX METALLOPROTEINASE-7
Abel Kolawole Oyebamiji, Sunday Adewale Akintelu, Kehinde Abraham Odelade, et al.
Química Nova (2023)
Open Access | Times Cited: 1

Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates
Necla Kulabaş, Merve Gürboğa, Özlem Bingöl Özakpınar, et al.
Fabad Journal of Pharmaceutical Sciences (2023)
Open Access

Page 1

Scroll to top